Acarbose
17 NDCs across 4 manufacturers|17 Generic,0 Brand
Acarbose is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Sep 6, 1995, and the first generic was approved May 7, 2008. FDA's Orange Book lists 15 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $6 million on Acarbose across 175,000 claims for 45,000 beneficiaries.
Acarbose is available as 17 NDCs from 4 manufacturers (17 generic, 0 brand), with NADAC prices from $0.17 to $0.27 per EA — a 62% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
17
17G / 0B
Manufacturers
4
competing in market
Price Spread
$0.17 – $0.27
per EA
7d Activity
avg +0.8% WoW · of 17 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Heritage Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
alpha-Glucosidase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
4 manufacturers producing ACARBOSE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ACARBOSE 100 MG TABLET | $0.2740 per EA | +0.76% |
ACARBOSE 100 MG TABLET | $0.2740 per EA | +0.76% |
ACARBOSE 100 MG TABLET | $0.2740 per EA | +0.76% |
ACARBOSE 100 MG TABLET | $0.2740 per EA | +0.76% |
ACARBOSE 100 MG TABLET | $0.2354 per EA | — |
ACARBOSE 100 MG TABLET | $0.2354 per EA | — |
ACARBOSE 50 MG TABLET | $0.1968 per EA | — |
ACARBOSE 50 MG TABLET | $0.1968 per EA | — |
ACARBOSE 25 MG TABLET | $0.1835 per EA | — |
ACARBOSE 25 MG TABLET | $0.1798 per EA | +2.15% |
ACARBOSE 25 MG TABLET | $0.1798 per EA | +2.15% |
ACARBOSE 25 MG TABLET | $0.1798 per EA | +2.15% |
ACARBOSE 25 MG TABLET | $0.1798 per EA | +2.15% |
ACARBOSE 50 MG TABLET | $0.1691 per EA | -0.39% |
ACARBOSE 50 MG TABLET | $0.1691 per EA | -0.39% |
ACARBOSE 50 MG TABLET | $0.1691 per EA | -0.39% |
ACARBOSE 50 MG TABLET | $0.1691 per EA | -0.39% |
Frequently Asked Questions
What is Acarbose used to treat?
Acarbose is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
When did Acarbose become available as a generic?
FDA approved the first generic Acarbose (ANDA) on May 7, 2008. The Orange Book currently lists 15 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Acarbose?
In 2024, Medicare Part D spent $6 million on Acarbose across 175,000 claims for 45,000 beneficiaries.
How many Acarbose products are on the market?
The Acarbose drug market contains 17 NDCs from 4 manufacturers — 17 generic and 0 brand products.
What is the price range for Acarbose?
NADAC reference prices for Acarbose range from $0.1691 to $0.2740 per EA — a 62% difference between cheapest and most expensive.
Which manufacturers make Acarbose?
4 manufacturers list Acarbose in NADAC. Ranked by number of NDCs, the largest are Heritage Pharmaceuticals Inc. (8), Chartwell RX LLC (3), Hikma Pharmaceuticals USA Inc. (3), Strides Pharma Inc. (3).
How has the price of Acarbose changed recently?
Over the past 7 days, 8 Acarbose NDCs rose and 4 fell, with a market-wide average change of +0.8%.